Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate-Reference-Cited by-同舟云学术

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate

Published:2008-02 Issue:2 Volume:32 Page:255-261
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Alimena Giuliana,Breccia Massimo,Luciano Luigia,Quarantelli Fabrizio,Diverio Daniela,Izzo Barbara,De Angelis Biagio,Mancini Marco,Latagliata Roberto,Carmosino Ida,Nanni Mauro,Picardi Marco,Rotoli Bruno,Mandelli Franco,Pane Fabrizio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990

2. Interferon alfa-2a compared with conventional chemotherapy for the treatment of chronic myeloid leukemia;N Engl J Med,1994

3. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea;Hehlmann;Leukemia,2003

4. Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission;Hochhaus;Blood,2000

5. Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders;Bonifazi;Blood,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia;Hematology;2013-07

2. Re-emergence of interferon-α in the treatment of chronic myeloid leukemia;Leukemia;2012-12-14

3. Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptor;Blood;2011-10-13

4. Imatinib is receptive to a collaboration;Blood;2011-10-13

5. Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells;Blood;2011-08-11